
Health Studies Hub
Your go-to source for daily breakdowns of the latest health, fitness, and nutrition research.
A Diabetes Drug Just Cut Migraines in Half—Here’s How.
A 2025 pilot study from the University of Naples “Federico II” found that the diabetes drug liraglutide (a GLP-1 receptor agonist) reduced monthly migraine days by over 50% in patients with chronic migraine.